Both in Pharmaceuticals
Xenon Pharmaceuticals vs Disc Medicine
Over the past year XENE returned −4.8% and IRON returned −2.4%; their daily moves had a correlation of 0.22.
XENE −4.8% IRON −2.4%Growth of $1, one year, split-adjusted
| Metric | XENE | IRON |
|---|---|---|
| Price | $39.14 | $82.66 |
| Market cap | $3.79B | $3.67B |
| Today | +2.38% | +1.84% |
| 1 month | +7.0% | +34.1% |
| 6 months | −33.2% | +20.4% |
| Year to date | −12.7% | +4.1% |
| 1 year | −4.8% | −2.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $930.7M | $658.4M |
| Dividend yield | — | — |
| Volatility (60d) | 82.6% | 75.8% |
| Short % of float | 8.1% | 22.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).